Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.
LATEST LUNG CANCER CONTENT
Key Considerations for Managing IO Toxicity in NSCLC
Reducing Chemotherapy Toxicity Using Trilaciclib in SCLC
Managing Chemotherapy-Induced Neutropenia in SCLC
Cemiplimab 5-Year Data Show Improved Survival in High PD-L1 NSCLC
Reviewing Key Trials Shaping IO Monotherapy in Advanced Lung Cancer
KRAS Inhibitors Show Efficacy in Randomized NSCLC Trials
Identifying Situations Where CTLA-4 Addition Improves NSCLC Outcomes
Patient Factors Determine Treatment Selection for PD-L1 Negative NSCLC
CASE-BASED ROUNDTABLES
Advertisement
Advertisement
